Skip to content

GEXHAM: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

GEXHAM

BE 0550.768.770
NACE 68.322, Real estate appraisal on a fee or contract basis
latest balance sheet 31-03-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€476,542 to €590,167

Midpoint €523,886 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €384,954
Capitalised earnings €568,129 to €795,380
Indication €476,542 to €590,167

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-03-2025
Equity (10/15)
€384,954
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€384,954

Capitalised earnings

net result for the year (9904)
2025
€100,740
2024
€35,042
2023
€102,832
2022
€80,655
2021
€27,838
Average result
€79,538
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€568,129 / €662,817 / €795,380

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 March 2025. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.